YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

Press Releases

BC Platforms Launches Personalized Precision Medicine Initiative with the University of Colorado Anschutz Medical Campus

HELSINKI, FINLAND - Oct 6, 2015 - BC Platforms, a world leader in genomic data management solutions, today announced that the University of Colorado Anschutz Medical Campus will use the company’s world-leading, comprehensive data management program to support  the launch of the university’s new personalized medicine initiative aiming at translating community genomics into individual well-being

Genomics England announces Congenica as an interpretation partner as it expands industry engagement

CAMBRIDGE, UK - Sep 30, 2015 - Tom Weaver, CEO of Cambridge-based Congenica is delighted that its technology is reaching patients and says; “One of the aims of Genomics England is to enable NHS patients to gain early benefit from advances in genomics and through participation in the 100,000 Genomes Project we have been able to accelerate development of our Sapientia™ diagnostic platform


CAMBRIDGE UK, UK - Sep 29, 2015 - Life Sciences Minister George Freeman MP today announced at the GREAT Healthcare Week at the Milan Expo, that Congenica, a world leading developer of genome-based discovery and diagnostic technologies, has been awarded £300,000 by Innovate UK as part of its ‘Finding value in complex data’ competition

Affordable large-scale DNA variation studies for every DNA researcher

HARDERWIJK, THE NETHERLANDS - Sep 24, 2015 - Today, GENALICE announced the global launch date of Population Calling, a new analysis module and part of their GENALICE MAP Next-Generation Sequencing (NGS) Data Analysis Suite

CSM to Celebrate Grand Opening of New Malvern Facility

MALVERN, PA - Sep 17, 2015 - CSM is pleased to announce that it will hold a Grand Opening and Ribbon-Cutting ceremony for its newly constructed facility at 300 Technology Drive in the Great Valley Corporate Center of Malvern, Pennsylvania on Thursday, October 15th from 1 p

Bio-specimen Grant Program Launched

MINNEAPOLIS, MN, UNITED STATES - Sep 14, 2015 - DaVita Clinical Research® (DCR®), a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its Biospecimen ResearchGrant Program (BioReG), a grant program to award clinical-trial-quality biospecimens and annotated de-identified data to academic medical centers involved in kidney research

Genedata at SBI2 will Showcase How Genedata Screener Industrializes HCS

CAMBRIDGE, MA, UNITED STATES - Sep 14, 2015 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, announced it will be among the presenters at the 2nd Annual Society of Biomolecular Imaging and Informatics (SBI2) Meeting

Government Incentive Programs to Boost the E-Prescribing Market

ALBANY, NY - Sep 14, 2015 - E-Prescribing is the system to broadcast information related to prescription among prescriber, dispenser, and pharmacy benefit manager electronically that allows a doctor and nurse to broadcast a new prescription electronically when any error in medication takes place at any stage in pharmacy operations

Growing Dependence and Popularity of the Computational Biology Market

ALBANY, NY - Sep 14, 2015 - Computational biology refers to the development of techniques for the collection, manipulation, and use of biological data to make discoveries and predictions

Certara and Paidion Research Form Partnership Focused on Improving Pediatric Drug Development

PRINCETON, NJ - Sep 10, 2015 - Certara®, the global biosimulation technology-enabled drug development company, and Paidion Research, Inc

Former Director of Clinical Pharmacology at CDER Appointed to Certara’s Simcyp Scientific Advisory Board

PRINCETON, NJ - Aug 20, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Lawrence J

Ashion Analytics™ launches genomic testing services designed to improve cancer care

PHOENIX, AZ, UNITED STATES - Aug 19, 2015 - Ashion Analytics, a CLIA certified and CAP-accredited molecular cancer testing laboratory, today announced its launch and the availability of its flagship product, the Genomic Enabled Medicine (GEM) Cancer Panel™ , to assist doctors in treating patients with cancer

Boston Medical Center Selects PFS Clinical for Coverage Analysis of Clinical Research Trials

MIDDLETON, WI, UNITED STATES - Aug 18, 2015 - PFS Clinical, which offers turnkey administration solutions that address the key pain points of establishing and running a clinical trial office, has been engaged by the Boston Medical Center (BMC) Clinical Trial Office to provide Medicare Coverage Analysis (CA) of its clinical research trials

Veracyte, Inc. Appoints Dr. Neil M. Barth as Chief Medical Officer

SOUTH SAN FRANCISCO, CA, UNITED STATES - Aug 17, 2015 - Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced the appointment of Neil M

Cloud Pharmaceuticals Strengthens Management Team with Appointment of Two C-Level Executives

RESEARCH TRIANGLE PARK, NC - Aug 17, 2015 - Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, today announced the appointment of two C-level executives to its management team

Certara Senior Scientific Advisor and Head of Simcyp Translational Science Dr. Iain Gardner Appointed to Xenobiotica Editorial Board

PRINCETON, NJ - Aug 10, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Iain Gardner, Ph

Punctuating Messages Encoded in Human Genome with Transposable Elements

SAN FRANCISCO, CA, UNITED STATES - Aug 4, 2015 - Since the classical studies of Jacob and Monod in the early 1960s, it has been evident that genome sequences contain not only blueprints for genes and the proteins that they encode, but also the instructions for a coordinated regulatory program that governs when, where and to what extent these genes and proteins are expressed

Rancho BioSciences and BT to Provide Big Data Cloud Services to Life Sciences Sector

SAN DIEGO, CA, UNITED STATES - Jul 14, 2015 - Rancho BioSciences, the Data Curation Company, today announced that they will work with BT to provide cloud-based data curation services to their joint customers

Creative Bioarray Introduces Whole Chromosome Painting Probes to Biological Researchers

NEW YORK, NY - Jul 20, 2015 - Creative Bioarray, an innovative biotechnology company who supplies research-use cells, cell culture medium and reagents, FISH probes, tissue array, microorganisms, equipments and related services, etc, has announced its Whole Chromosome Painting Probes to bio-research community

Synexus continues expansion across Eastern Europe with three new clinical trial centres

CHORLEY, UNITED KINGDOM - Jul 15, 2015 - Synexus continues to expand across Eastern Europe with three new Dedicated Research Centres in Bulgaria, Poland and Romania, bringing the total to nine centres in Eastern Europe and a total network of 25 across Europe and Africa

For reprints and/or copyright permission, please contact Terry Manning, 781.972.1349.